Occudo Quantitative Strategies LP Abbott Laboratories Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $2.19 Million - $2.44 Million	21,712 New	21,712 $2.26 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $3.22 Million - $3.89 Million	-31,567 Reduced 59.83%	21,192 $2.3 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $5.37 Million - $6.55 Million	47,132 Added 837.6%	52,759 $6.25 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $650,087 - $795,995	5,627 New	5,627 $792,000
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $350,329 - $387,567	-3,003 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $317,687 - $373,963	3,003 New	3,003 $348,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.